BRISTOL-MYERS SQUIBB CO (BMY)

US1101221083 - Common Stock

54.23  +0.98 (+1.84%)

After market: 54 -0.23 (-0.42%)

News Image
21 hours ago - The Motley Fool

Is Bristol Myers Squibb Stock a Buy?

The company is going through a rough patch.

News Image
21 hours ago - Investor's Business Daily

Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback

The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.

News Image
a day ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bristol-Myers Squibb Company ("Bristol Myers" or the "Company") (NYSE: BMY)....

News Image
2 days ago - InvestorPlace

The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio

With a possible rotation away from the technology space, these are the undervalued healthcare stocks to consider.

News Image
8 days ago - Market News Video

BMY May 3rd Options Begin Trading

News Image
9 days ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bristol-Myers Squibb Company ("Bristol Myers" or the "Company") (NYSE: BMY)....

News Image
14 days ago - Bloomberg

Bristol Myers Wins FDA Approval of CAR-T for Some Blood Cancers

Bristol Myers Squibb Co. won accelerated approval for the first CAR-T therapy for adults with two forms of hard-to-treat leukemia or lymphoma.

News Image
17 days ago - Chartmill

Why NYSE:BMY is a Top Pick for Dividend Investors.

Is BRISTOL-MYERS SQUIBB CO (NYSE:BMY) a Good Fit for Dividend Investing?